Multaq
Nasal Decongestants Taken in First Trimester can Lead to Birth Defect
Nasal Decongestants May Cause Birth Defect. Women who take nasal decongestants in the first trimester of their pregnancy may be raising the risk that their newborn will suffer from one or more rare birth defects, according to a new study. Researchers at the Slone Epidemiology Center at Boston University found that phenylephrine, … [Read more...] about Nasal Decongestants Taken in First Trimester can Lead to Birth Defect
Multaq Doubles Heart Disease Death Risk
Multaq Doubles Heart Disease Death Risk. A new study has revealed a connection between Multaq (dronedarone), approved to treat temporary atrial fibrillation, and a two-fold risk of death in those who suffer from permanent erratic cardiac rhythm. The study found that, in addition to the death risk, stroke and heart … [Read more...] about Multaq Doubles Heart Disease Death Risk
Use of Multaq Should be Curbed
Multaq Safety Issues. Multaq safety worries have prompted regulators to issue new restrictions for the drug. According to a report from The Wall Street Journal, concerns about Multaq's impact on the heart, lungs and liver might soon prompt the U.S. Food & Drug Administration (FDA) to take similar steps in the … [Read more...] about Use of Multaq Should be Curbed
Multaq Losing Favor
Multaq Safety Concerns. Multaq is coming under increasing scrutiny in both the U.S. and Europe as concerns about its safety and effectiveness continue to mount. At the same time, many doctors appear to be backing away from Multaq because of safety concerns. Multaq is approved to treat temporary atrial fibrillation. In … [Read more...] about Multaq Losing Favor
Multaq Heart Risks Prompt Review
Multaq Heart Risks Prompt. Multaq, already under scrutiny in the U.S. and Europe because of a link to potentially serious heart side effects, is being reviewed by regulators in Canada. As was the case elsewhere, the Health Canada Multaq review was prompted by the halt of a Multaq study because of a high number of severe heart-related … [Read more...] about Multaq Heart Risks Prompt Review
Multaq Alert after Clinical Trial Halted
FDA Has Issued A Multaq Alert. The U.S. Food & Drug Administration (FDA) has issued a safety alert for the drug Multaq, after a clinical trial for the drug was halted due to a higher-than-expected number of heart problems among study participants. The agency is advising Multaq users to speak with their doctors as … [Read more...] about Multaq Alert after Clinical Trial Halted
